Skip to main content
. 2023 Nov 3;14:1242250. doi: 10.3389/fendo.2023.1242250

Table 4.

Comparison of data between unilateral tumor group and bilateral tumor group in PTC patients.

Subject Unilateral tumor Bilateral tumors t/Z p
Number (%) 142 (50.90) 137 (49.10) - -
Age (years) 45.00 (35.00 - 52.00) 43.00 (35.00 - 52.50) -0.458 0.647
SSL (μg/L) 82.70 (72.55 - 89.43) 76.90 (70.05 - 85.05) -2.871 0.004
BMI (kg/m2) 25.52 ± 3.91 26.66 ± 3.90 -2.436 0.015
Height (cm) 163.00 (160.00 - 170.00) 164.00 (160.00 - 170.00) -0.036 0.971
Weight (kg) 66.50 (59.00 - 78.50) 70.00 (62.00 - 81.00) -2.129 0.033
Waist (cm) 88.00 (83.00 - 97.00) 92.00 (84.25 - 98.75) -1.949 0.051
SBP (mmHg) 122.00 (112.75 - 132.25) 124.00 (114.50 - 138.00) -1.316 0.188
DBP (mmHg) 78.00 (71.75 - 86.00) 80.00 (74.00 - 92.00) -2.364 0.018
FT3 (pmol/L) 4.92 (4.56 - 5.19) 5.07 (4.69 - 5.87) -0.107 0.915
FT4 (pmol/L) 17.59 (15.40 - 20.12) 18.06 (16.97 - 19.65) -0.721 0.471
TSH (uIU/mL) 2.04 (1.14 - 3.00) 1.49 (1.26 - 2.42) -1.477 0.140
TPOAB (IU/mL) 13.08 (10.01 - 20.00) 12.67 (10.07 - 20.49) -0.398 0.690
TGAB (IU/mL) 19.79 (15.06 - 44.08) 21.30 (16.03 - 55.02) -0.820 0.412

SSL, serum selenium level; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid stimulating hormone; TPOAB, thyroidperoxidase antibodies; TGAB, thyroglobulin antibody.